Inhibition of influenza A virus infection in vitro by peptides designed in silico.
Influenza A viruses are enveloped, segmented negative single-stranded RNA viruses, capable of causing severe human respiratory infections. Currently, only two types of drugs are used to treat influenza A infections, the M2 H(+) ion channel blockers (amantadine and rimantadine) and the neuraminidase...
Main Authors: | Rogelio López-Martínez, G Lizbeth Ramírez-Salinas, José Correa-Basurto, Blanca L Barrón |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3795628?pdf=render |
Similar Items
-
The Entry Blocker Peptide Produced in Chlamydomonas reinhardtii Inhibits Influenza Viral Replication in vitro
by: Karen Lizbeth Reyes-Barrera, et al.
Published: (2021-05-01) -
In Silico and In Vitro Analysis of Multifunctionality of Animal Food-Derived Peptides
by: Lourdes Amigo, et al.
Published: (2020-07-01) -
Repositioning of Ligands That Target the Spike Glycoprotein as Potential Drugs for SARS-CoV-2 in an In Silico Study
by: Gema Lizbeth Ramírez-Salinas, et al.
Published: (2020-11-01) -
Enhanced inhibition of influenza virus infection by peptide–noble-metal nanoparticle conjugates
by: Zaid K. Alghrair, et al.
Published: (2019-05-01) -
Inhibition of herpes simplex virus-1 infection by MBZM-N-IBT: in silico and in vitro studies
by: Abhishek Kumar, et al.
Published: (2021-05-01)